Travel Medicine and Infectious Disease最新文献

英文中文

A possible case of cutaneous histoplasmosis and mpox coinfection 一例可能的皮肤组织胞浆菌病和 mpox 合并感染病例。

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-05-01 DOI: 10.1016/j.tmaid.2024.102700

Jesus Alberto Cardenas-de la Garza, Ana Carolina Manzotti-Rodriguez, Pablo Gamez-Siller, Anahí Carrazco-Chapa, Gloria Mayela Aguirre-Garcia, Rodolfo Franco-Marquez, Hersilia Aide Hernández-Zamonsett, Maria Teresa Ramirez-Elizondo, Dionicio Angel Galarza-Delgado, Reynaldo Lara-Medrano

引用次数: 0

A rare case of severe pneumonia combined with septic shock caused by Nocardia amamiensis 一例由 amamiensis 诺卡氏菌引起的重症肺炎合并脓毒性休克的罕见病例。

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-05-01 DOI: 10.1016/j.tmaid.2024.102710

Jishan Tan , Bo Huang , Shuhong Luo, Rongyang Li, Juanni Hou, Ru Zhang, Lu Wang , Yuan Liu, Fuxiang Li, Jian Feng

引用次数: 0

Dramatic re-emergence of avian influenza in Colombia and Latin America 哥伦比亚和拉丁美洲再次出现禽流感疫情。

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-05-01 DOI: 10.1016/j.tmaid.2024.102711

Daniela Paternina, Rene Herazo, Misael Oviedo, Salim Mattar

引用次数: 0

Surveillance cystoscopy for atypical Schistosoma haematobium infection associated with recurrent UTIs 监测膀胱镜检查与复发性尿毒症相关的非典型血吸虫感染。

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-05-01 DOI: 10.1016/j.tmaid.2024.102702

Case Keltner, Jacqueline Causbie, Robert Haynes, Jeremy Mandia, Hisham Imad, Wasin Matsee

引用次数: 0

The never-ending story of mpox epidemic: Tracing a new cluster in Florence, Italy 水痘疫情的故事永无止境：追踪意大利佛罗伦萨的新疫情群。

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-05-01 DOI: 10.1016/j.tmaid.2024.102704

Luigi Pisano, Manfredi Magliulo, Martina Turco, Jacopo Farini, Anna Lisa Rapaccini, Filippo Lagi, Alessandro Bartoloni, Nicola Pimpinelli

引用次数: 0

Trends in temporal and spatial changes of Japanese encephalitis in Chinese mainland, 2004–2019: A population-based surveillance study 2004-2019年中国大陆日本脑炎的时空变化趋势：一项基于人群的监测研究。

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-04-29 DOI: 10.1016/j.tmaid.2024.102724

Chang-Qing Sun , Yun-Qiang Fu , Xuan Ma , Jun-Ru Shen , Bo Hu , Qiang Zhang , Lian-Ke Wang , Rui Hu , Jia-Jun Chen

Background

Japanese encephalitis (JE) is a serious health concern in China, with approximately 80 % of global infections occurring in China. To develop effective prevention and control strategies, this study explored the epidemiological characteristics of JE in China based on spatiotemporal data, to understand the patterns and trends of JE incidence in different regions and time periods.

Method

The incidence and mortality rates of JE were extracted from the Public Health Data Center, the official website of the National Health Commission of the People's Republic of China, and the National Notifiable Infectious Disease Surveillance System from 2004 to 2019. Joinpoint regression was applied to examine the spatiotemporal patterns and annual percentage change in incidence and mortality of the JE.

Results

From 2004 to 2019, a total of 43,569 cases of JE were diagnosed, including 2081 deaths. The annual incidence rate of JE decreased from 0.4171/100,000 in 2004 to 0.0298/100,000 in 2019, with an annual percentage change (APC) of −13.5 % (P < 0.001). The annual mortality rate of JE showed three stages of change, with inflection points in 2006 and 2014. The incidence and mortality rates of JE have declined in all provinces of China, and more cases were reported in 0–14 years of age, accounting for nearly 80 % of all patients.

Conclusions

The morbidity and mortality rates of JE in China are generally on a downward trend, and emphasis should be placed on strengthening disease surveillance in special areas and populations, popularizing vaccination, and increasing publicity.

背景：日本脑炎（JE）在中国是一个严重的健康问题，全球约80%的感染发生在中国。为了制定有效的预防和控制策略，本研究基于时空数据探讨了中国日本脑炎的流行病学特征，以了解不同地区和不同时期日本脑炎的发病模式和趋势：方法：从公共卫生数据中心、中华人民共和国国家卫生健康委员会官方网站和全国报告传染病监测系统中提取2004-2019年JE的发病率和死亡率。结果表明，2004-2019年，全国共发生了5例肺结核，其中1例为急性肺结核，1例为慢性肺结核：从 2004 年到 2019 年，共确诊 43 569 例 JE 病例，其中 2 081 例死亡。JE的年发病率从2004年的0.4171/10万降至2019年的0.0298/10万，年百分比变化率（APC）为-13.5%（PConclusions：我国JE发病率和死亡率总体呈下降趋势，应重点加强特殊地区和人群的疫情监测，普及疫苗接种，加大宣传力度。

{"title":"Trends in temporal and spatial changes of Japanese encephalitis in Chinese mainland, 2004–2019: A population-based surveillance study","authors":"Chang-Qing Sun , Yun-Qiang Fu , Xuan Ma , Jun-Ru Shen , Bo Hu , Qiang Zhang , Lian-Ke Wang , Rui Hu , Jia-Jun Chen","doi":"10.1016/j.tmaid.2024.102724","DOIUrl":"10.1016/j.tmaid.2024.102724","url":null,"abstract":"<div><h3>Background</h3><p>Japanese encephalitis (JE) is a serious health concern in China, with approximately 80 % of global infections occurring in China. To develop effective prevention and control strategies, this study explored the epidemiological characteristics of JE in China based on spatiotemporal data, to understand the patterns and trends of JE incidence in different regions and time periods.</p></div><div><h3>Method</h3><p>The incidence and mortality rates of JE were extracted from the Public Health Data Center, the official website of the National Health Commission of the People's Republic of China, and the National Notifiable Infectious Disease Surveillance System from 2004 to 2019. Joinpoint regression was applied to examine the spatiotemporal patterns and annual percentage change in incidence and mortality of the JE.</p></div><div><h3>Results</h3><p>From 2004 to 2019, a total of 43,569 cases of JE were diagnosed, including 2081 deaths. The annual incidence rate of JE decreased from 0.4171/100,000 in 2004 to 0.0298/100,000 in 2019, with an annual percentage change (APC) of −13.5 % (<em>P</em> < 0.001). The annual mortality rate of JE showed three stages of change, with inflection points in 2006 and 2014. The incidence and mortality rates of JE have declined in all provinces of China, and more cases were reported in 0–14 years of age, accounting for nearly 80 % of all patients.</p></div><div><h3>Conclusions</h3><p>The morbidity and mortality rates of JE in China are generally on a downward trend, and emphasis should be placed on strengthening disease surveillance in special areas and populations, popularizing vaccination, and increasing publicity.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"60 ","pages":"Article 102724"},"PeriodicalIF":12.0,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000383/pdfft?md5=e5f8b4749a818d1f02f7a2e72667a5ea&pid=1-s2.0-S1477893924000383-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140860443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Prevalence of crimean Congo hemorrhagic fever in Khyber Pakhtunkhwa, Pakistan 巴基斯坦开伯尔巴图克瓦省的刚果出血热流行情况

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-04-18 DOI: 10.1016/j.tmaid.2024.102722

Asad Zia , Ali Talha Khalil , Naz Alam , Abdul Qadoos Khan , Mubarak Ali Khan , Yasar Yosafzai , Asif Ali , Ihsan Ullah , Ali Rehman Wazir

Background

CCHFV is well recognized as a major public health threat and its prevalence and epidemiological distribution in Pakistan and specifically in KP province is not well documented.

Methods

We used a gold-standard PCR-based diagnostic assay for confirmation of CCHFV among suspected patients. A total of 150 patients were enrolled from June 2022 to September 2022 and their blood samples were collected for PCR confirmation.

Results

The overall positivity rate for CCHFV was 26.67 %, with the virus mostly prevalent in the middle-aged group (21–40 years). In the July of 2022, a significant spike in the prevalence of CCHFV was observed in provincial capital Peshawar with the highest burden (31.57 %).

Conclusion

Our findings indicate the necessity of strengthening CCHFV monitoring programs and intensifying efforts to identify hotspot regions for effective surveillance and control of CCHFV. The months before the Eid-ul-Adha are crucial in the context of CCHFV control.

背景CCHFV被公认为是一种重大的公共卫生威胁，但其在巴基斯坦，特别是在KP省的流行率和流行病学分布却没有得到很好的记录。结果CCHFV的总体阳性率为26.67%，病毒主要流行于中年群体（21-40岁）。结论我们的研究结果表明，有必要加强 CCHFV 监测项目，并加大力度确定热点地区，以有效监测和控制 CCHFV。宰牲节前的几个月是控制 CCHFV 的关键时期。

{"title":"Prevalence of crimean Congo hemorrhagic fever in Khyber Pakhtunkhwa, Pakistan","authors":"Asad Zia , Ali Talha Khalil , Naz Alam , Abdul Qadoos Khan , Mubarak Ali Khan , Yasar Yosafzai , Asif Ali , Ihsan Ullah , Ali Rehman Wazir","doi":"10.1016/j.tmaid.2024.102722","DOIUrl":"https://doi.org/10.1016/j.tmaid.2024.102722","url":null,"abstract":"<div><h3>Background</h3><p>CCHFV is well recognized as a major public health threat and its prevalence and epidemiological distribution in Pakistan and specifically in KP province is not well documented.</p></div><div><h3>Methods</h3><p>We used a gold-standard PCR-based diagnostic assay for confirmation of CCHFV among suspected patients. A total of 150 patients were enrolled from June 2022 to September 2022 and their blood samples were collected for PCR confirmation.</p></div><div><h3>Results</h3><p>The overall positivity rate for CCHFV was 26.67 %, with the virus mostly prevalent in the middle-aged group (21–40 years). In the July of 2022, a significant spike in the prevalence of CCHFV was observed in provincial capital Peshawar with the highest burden (31.57 %).</p></div><div><h3>Conclusion</h3><p>Our findings indicate the necessity of strengthening CCHFV monitoring programs and intensifying efforts to identify hotspot regions for effective surveillance and control of CCHFV. The months before the Eid-ul-Adha are crucial in the context of CCHFV control.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"59 ","pages":"Article 102722"},"PeriodicalIF":12.0,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S147789392400036X/pdfft?md5=a579dde5635a4b4c9e163773ff9aed68&pid=1-s2.0-S147789392400036X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140620907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mosquito-borne ross river virus: A raising concern in Queensland 蚊子传播的罗斯河病毒：昆士兰州日益令人担忧的问题

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-04-18 DOI: 10.1016/j.tmaid.2024.102723

Shriyansh Srivastava, Sachin Kumar, Sampath Chinnam, Naina Srivastava, Rachana Mehta, Aroop Mohanty, Sanjit Sah, Jack Feehan, Maximilian de Courten, Vasso Apostolopoulos , Ranjit Sah

引用次数: 0

Emerging threats: Is highly pathogenic avian influenza A(H5N1) in dairy herds a prelude to a new pandemic? 新出现的威胁：奶牛场中的高致病性禽流感 A(H5N1)是新的大流行的前奏吗？

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-04-07 DOI: 10.1016/j.tmaid.2024.102721

Francesco Branda, Chiara Romano, Marta Giovanetti, Alessandra Ciccozzi, Massimo Ciccozzi, Fabio Scarpa

引用次数: 0

Gastrointestinal syndrome encountered during a train voyage to high altitudes: A 14-day survey of 69 passengers in China 高海拔地区火车旅行中遇到的胃肠道综合征：对中国 69 名乘客进行的为期 14 天的调查

IF 12 3区医学 Q1 INFECTIOUS DISEASES

Travel Medicine and Infectious Disease

Pub Date : 2024-04-04 DOI: 10.1016/j.tmaid.2024.102718

Yihui Chen , Xiaoqi Tang , Xiong Zeng , Ben Han , Huichao Xie , Wei Wang , Lihua Sun , Mingdong Hu , Yuqi Gao , Weidong Xiao

Background

The diagnosis and evaluation of the severity of acute mountain sickness (AMS) continue to be problematic due to a lack of consensus on the inclusion of symptoms in a scoring system. Recent investigations highlight the significance of gastrointestinal symptoms in identifying this condition. However, the specific gastrointestinal symptoms associated with AMS have not been thoroughly elucidated in previous studies, and the underlying risk factors remain inadequately comprehended.

Methods

This study aimed to investigate the characteristics, trends, and risk factors related to gastrointestinal symptoms encountered during train travel to high altitude. A total of 69 passengers, specifically all with medical backgrounds, were surveyed 6 times over a period of 14 days.

Results

The daily incidence of abdominal discomfort was higher than non-gastrointestinal symptoms within 14 days. Gastrointestinal symptoms demonstrated a greater prevalence, longer duration, and increased risk compared to non-gastrointestinal symptoms, such as headaches. The symptoms of abdominal distension and bowel sound hyperaction were found to be prevalent and persistent among patients diagnosed with AMS, exhibiting a high incidence rate. Gender, age, body mass index (BMI), smoking habits, and alcohol consumption were identified as risk factors associated with the occurrence and duration of gastrointestinal symptoms.

Conclusion

This study suggests that gastrointestinal symptoms are more common and persistent when traveling to the plateau by train. These symptoms should be taken into consideration in the further diagnosis and prevention of AMS. Therefore, this study provides a significant theoretical foundation for the prevention and treatment of AMS.

背景由于在将症状纳入评分系统方面缺乏共识，诊断和评估急性登山病（AMS）的严重程度仍然是个难题。最近的研究强调了胃肠道症状在识别这种病症方面的重要性。本研究旨在调查前往高海拔地区的火车旅行中出现的胃肠道症状的特征、趋势和相关风险因素。结果在 14 天内，每日腹部不适的发生率高于非胃肠道症状。与头痛等非胃肠道症状相比，胃肠道症状的发生率更高、持续时间更长、风险更大。在确诊为急性胃肠炎的患者中，腹胀和肠鸣音亢进症状普遍存在且持续时间较长，发病率较高。性别、年龄、体重指数（BMI）、吸烟习惯和饮酒被认为是与胃肠道症状的发生和持续时间相关的风险因素。在进一步诊断和预防 AMS 时应考虑到这些症状。因此，本研究为预防和治疗高原反应提供了重要的理论依据。

{"title":"Gastrointestinal syndrome encountered during a train voyage to high altitudes: A 14-day survey of 69 passengers in China","authors":"Yihui Chen , Xiaoqi Tang , Xiong Zeng , Ben Han , Huichao Xie , Wei Wang , Lihua Sun , Mingdong Hu , Yuqi Gao , Weidong Xiao","doi":"10.1016/j.tmaid.2024.102718","DOIUrl":"https://doi.org/10.1016/j.tmaid.2024.102718","url":null,"abstract":"<div><h3>Background</h3><p>The diagnosis and evaluation of the severity of acute mountain sickness (AMS) continue to be problematic due to a lack of consensus on the inclusion of symptoms in a scoring system. Recent investigations highlight the significance of gastrointestinal symptoms in identifying this condition. However, the specific gastrointestinal symptoms associated with AMS have not been thoroughly elucidated in previous studies, and the underlying risk factors remain inadequately comprehended.</p></div><div><h3>Methods</h3><p>This study aimed to investigate the characteristics, trends, and risk factors related to gastrointestinal symptoms encountered during train travel to high altitude. A total of 69 passengers, specifically all with medical backgrounds, were surveyed 6 times over a period of 14 days.</p></div><div><h3>Results</h3><p>The daily incidence of abdominal discomfort was higher than non-gastrointestinal symptoms within 14 days. Gastrointestinal symptoms demonstrated a greater prevalence, longer duration, and increased risk compared to non-gastrointestinal symptoms, such as headaches. The symptoms of abdominal distension and bowel sound hyperaction were found to be prevalent and persistent among patients diagnosed with AMS, exhibiting a high incidence rate. Gender, age, body mass index (BMI), smoking habits, and alcohol consumption were identified as risk factors associated with the occurrence and duration of gastrointestinal symptoms.</p></div><div><h3>Conclusion</h3><p>This study suggests that gastrointestinal symptoms are more common and persistent when traveling to the plateau by train. These symptoms should be taken into consideration in the further diagnosis and prevention of AMS. Therefore, this study provides a significant theoretical foundation for the prevention and treatment of AMS.</p></div>","PeriodicalId":23312,"journal":{"name":"Travel Medicine and Infectious Disease","volume":"59 ","pages":"Article 102718"},"PeriodicalIF":12.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1477893924000322/pdfft?md5=ff8c3c86052e358f220d0566bb34855d&pid=1-s2.0-S1477893924000322-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140535954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Travel Medicine and Infectious Disease

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀